Objective. Oral and injected steroids are used commonly in the treatment of cervical radicular pain despite a paucity of data demonstrating their efficacy. The purpose of this study is to assess whether the response to orally administered steroids among patients with acute cervical radicular pain who develop recurrent pain is associated with their subsequent response to cervical epidural steroid injections.
Introduction
Steroids administered either orally or via injection into the epidural space are used regularly to treat the pain associated with acute cervical radicular pain. Some patients will experience a profound but transient pain reduction with a brief course of systemic steroid [1] . Data for use of oral steroids are lacking, although this medication is often used in practice. Many of these patients will be offered an epidural steroid injection when their pain recurs. The rationale is that injecting the steroid close to the ostensible site of pathology results in a higher local dose and a more durable response.
Oral and injected steroids are used commonly in the treatment of cervical radicular pain despite a paucity of data demonstrating their efficacy. One study shows a small positive effect for oral steroids used to treat acute sciatica of the lower extremity [2] . Goldberg et al. showed that orally administered steroid in patients with an acute lumbar herniated nucleus pulposus resulted in a small improvement in functional status vs controls [3] .
A similar improvement in pain was not observed. Our accumulated experience in a busy spine practice is consistent with the notion that there is a discrete group of patients who do respond to such therapy.
Although studies have been conducted assessing the effect of epidural injections for spine-related symptoms, there are few high-quality data available and the results are mixed for both lumbar and cervical procedures [4] [5] [6] [7] . This literature is compromised by heterogeneity of inclusion criteria and injection technique. More recent studies showed better improvement when cervical epidural injections were used as part of a multidisciplinary approach, including physical therapy and oral neuromodulators [8, 9] .
If there were a correlation between pain reduction with oral steroid treatment and cervical epidural steroid injections, physicians would be able to more appropriately tailor steroid therapy in patients with acute cervical radicular pain. The primary purpose of this present study is to assess whether the response to orally administered steroids among patients with acute cervical radicular pain who develop recurrent pain is associated with their subsequent response to cervical epidural steroid injections. In addition, we provide data describing the time course of pain reduction reported by patients after cervical epidural steroid injection.
Materials and Methods

Study Group
Patients with acute cervical radicular pain who were referred internally to our interventional spine center for a cervical epidural steroid injection were potentially eligible for enrollment in this prospective cohort study. Following the standard protocol at our practice, patients underwent an initial evaluation by either one of our surgeons or physiatrists. At the discretion of this initial provider, patients were then referred internally to one of a group of three interventional physicians for an epidural injection. These physicians all received their board certification in anesthesiology from the American Board of Anesthesiology (ABA), completed a fellowship in pain management, and received a certificate of added qualification in pain medicine from the ABA.
Individuals who were at least 18 years of age at the time of referral and who had unilateral neck and arm symptoms of at least six weeks' duration extending below the elbow in a dermatomal distribution and had undergone magnetic resonance imaging of the cervical spine in the past six months were eligible for inclusion in the study. A further criterion was oral steroid use during the past six weeks; this was determined by the interventional pain physician on the day of the scheduled injection. Magnetic resonance imaging (MRI) studies were evaluated to assess the safety of needle placement at the C7-T1 interlaminar aperture. We did not intend to correlate imaging findings with clinical symptoms.
Cervical MRIs performed in the absence of symptoms demonstrate abnormalities in 19% of patients [10] . MRI does not allow an assessment of the degree of inflammation present in any individual case. In all cases, however, patients included in this study had MRI findings consistent with central canal stenosis, lateral recess stenosis, foraminal stenosis, or some combination of the three. Exclusion criteria were clinically significant weakness; history of previous cervical spine surgery; anatomy on MRI not compatible with safe placement of an injection at C7-T1; history of previous cervical epidural steroid injections; current therapy with warfarin, lowmolecular weight heparin, or antiplatelet agents that cannot be discontinued to facilitate injection; systemic infection; skin infection at the desired site of needle placement; history of allergy to iodinated contrast; therapy with oral steroids within the previous week; no prior treatment with oral steroids for this episode of pain: pregnancy; history of renal failure; history of upper GI bleeding; history of major psychiatric disease; and presence of symptoms and/or a medical history that suggests increased risk for serious underlying disease as defined by the United States Agency for Health Care Policy Research [11] .
Those who met the criteria were offered participation in the study. Informed consent was obtained for the injection itself and separately for inclusion in the study protocol. Both consents were obtained by the interventional provider. Patients were treated according to usual practice, regardless of their eligibility or enrollment status. Follow-up beyond that required for participation in the study was at the discretion of the initial evaluating provider. This study was reviewed and approved by Maine Medical Center's Institutional Review Board.
Clinical Procedure
The procedures were performed at one of two outpatient pain centers by one of three board-certified interventional pain physicians using our center's standard protocol. Patients were placed prone on a fluoroscopy table with the neck in flexion. The C7-T1 interlaminar space was the point of needle entry for all patients. An 18 gauge Touhy needle was used to enter the epidural space with a loss-of-resistance to preservative-free normal saline technique. The needle was directed toward the painful side via a para-sagittal approach. Fluoroscopy was used to document AP and oblique images. Iodinated contrast was introduced to document the proper placement of the needle within the epidural space such that no intrathecal or intravascular placement was demonstrated. Approximately 0.5 mL of iodinated contrast was injected under live fluoroscopy to document spread of the injectate to the appropriate side of the vertebral column. Patients were allowed repeat injections, up to a total of three in the six-month period, commencing with the first injection according to the standard protocol for this treatment paradigm. A total of 12 mg of preservative-free betamethasone (6 mg per ml) was injected with 2 mL of preservative-free normal saline, for a total volume of 4 mL.
Data Collection
On the day of the first injection, patients completed a retrospective assessment documenting the duration of symptoms. Patients reported the greatest degree of relief obtained from oral steroids, expressed as 0-100% pain reduction, and how many days of relief were obtained during treatment with oral steroids. For data analysis, reduction of pain with oral steroids was defined as any report of greater than 0% pain relief during the course of oral steroid treatment and oral steroid relief was expressed as a binary variable (yes/no). The patients then completed the Brief Pain Inventory Short Form to characterize their baseline pain [12, 13] . Pain at baseline and during follow-up after cervical epidural steroid injection was scored on a numeric rating scale (NRS) of 0 to 10, with 0 representing no pain and 10 representing worst possible pain. At subsequent time points, complete pain relief was defined as a decrease from baseline NRS to an NRS of 0, and partial pain relief was defined as an NRS that was less than the baseline value but greater than 0. Differences in NRS scores between time points were expressed as a percentage. We stratified partial pain relief as 50% or less relief and greater than 50% relief. Demographic, clinical, and procedural data were obtained from the medical record.
Patients were contacted by the department's research coordinator (JMR) via telephone one week, one month, three months, and six months postinjection to complete the Brief Pain Inventory Short Form [13] . A total of three attempts were made to contact each patient for each follow-up interval; if none of the attempts were successful, the interval was left incomplete.
Statistical Analysis
The study was designed with 80% power to detect a 50% difference in NRS score at six months between patients who reported any pain reduction with oral steroids and those who reported no pain reduction with oral steroids. Descriptive data were summarized as mean (SD) and median (where informative) for continuous data and as frequency (N, %, 95% confidence interval) for categorical data. Comparisons between subgroups were performed by t test (continuous data) or chi square test (categorical data) as appropriate.
In post hoc analysis, we examined the effect of time since cervical steroid injection on NRS scores in the overall study group without stratification by pain reduction with oral steroid treatment; there was no predetermined statistical power for these analyses. To account for the high prevalence of missing data, we used mixed model analysis with maximum likelihood estimation. Time, response to oral steroids, and interaction (time x oral steroid response) were entered into the model. Additional post hoc analyses comparing pain between sequential time points were performed by paired t tests, with Bonferroni adjustment for multiple comparisons.
We also examined the effect of time since cervical injection in the subgroup of 30 patients with complete data using repeated measures analysis of variance (ANOVA), with both time and pain reduction (yes/no) with oral steroids entered as factors. Post hoc analyses of differences in pain between sequential time points were performed by paired t tests, with Bonferroni adjustment for multiple comparisons.
We calculated the frequency of clinical outcomes at each time point in comparison with baseline pain; outcome categories were surgery, worse pain, no change in pain, partial pain relief of 50% or less, partial pain relief greater than 50%, and complete pain relief. To assess the potential impact of missing data, these outcome frequencies were first calculated by excluding missing cases by time point. Then, to model alternative scenarios, we included missing data points in either the "no change in pain" or the "worse pain" subgroups and recalculated the distribution of pain relief categories.
All analyses were performed using IBM SPSS Statistics version 20 (IBM Corporation, Armonk, NY, USA). Figure 1 shows the disposition of the study group over six months. We enrolled 75 patients; three did not provide complete baseline data and were excluded from further analysis (N ¼ 72). During the course of the study, 16 (22.2%) patients elected surgery and 17 (23.6%) were lost to follow-up. Between those who did and did not experience pain reduction with oral steroids, there was no significant difference in the frequency of surgery (10, 20 .0%, and 6, 27.3%, respectively, P ¼ 0.54) or loss to follow-up (10, 20.0%, and 7, 31.8%, respectively, P ¼ 0.37). Of the 39 (54.2%) patients who provided NRS data in the study for six months, 30 provided complete data series. Over the course of the study, 21 (29.2%) patients received a second steroid injection; 10 at one month, six at three months, and five at six months. Overall (N ¼ 72), MRI abnormalities were found in the foramen (N ¼ 37, 16 with herniated nucleus pulposus [HNP]); lateral recess (N ¼ 22, 17 with HNP), both foramen and lateral recess (N ¼ 9, 6 with HNP); both lateral recess and central canal (N ¼ 3, 1 with HNP); and there was one case with HNP only. Crovo et al. data points available are described for each variable in the table legend. Age, duration of symptoms, and sex did not vary significantly between those who reported prior pain reduction with oral steroids compared with those who reported no pain reduction. Table 2 shows pain (NRS) data for patients providing data at each time point, stratified by reported response to oral steroids. There was no significant difference in NRS at six months between those reporting any pain reduction or no pain reduction with oral steroid treatment (P ¼ 0.88). Data for the overall group are further illustrated in Figure 2A . In this post hoc analysis, the decrease from baseline pain scores during the six months after cervical steroid injection was significant (P time < 0.001 by mixed models analysis); prior pain reduction with oral steroids (P oral_steroid_response ¼ 0.44) and the interaction (time x oral steroid response) term (P timeXoral_steroid_response ¼ 0.76) had no significant effect. Pairwise comparison between adjacent time points demonstrated that the mean decrease in pain score (-1.9) between baseline and the first week after cervical steroid injection was significant (P < 0.001 by t test); differences between subsequent time points were not significant.
Results
To investigate the effect of missing data on the relationship between pain scores and time after cervical steroid injection, we performed a subset analysis of the 30 patients with a complete time series of data ( Figure 2B ). The findings were similar to those shown in Figure 2A for the overall group, with mean pain scores of 5.
, and 1.8 (SD ¼ 2.1, median ¼ 1) at baseline, one week, and one, three, and six months, respectively. Again, there was a significant effect of time since cervical steroid injection on average pain scores (P < 0.001 by repeated measures ANOVA); there was also no significant group effect (response to oral steroids, P ¼ 0.08) and no group x time interaction (P ¼ 0.30). Average pain scores decreased significantly between baseline and one week (P < 0.001 by paired t test) and again between one week and one month (P ¼ 0.028 by paired t test), but not between subsequent time points. Table  3A , patients with missing data in a given survey were excluded from outcome frequency calculations at that time point and any interpretation of the data assumes that their outcomes were randomly distributed. Consistent with the overall pain data shown in Figure 2 , outcome patterns stabilized after three months. At six months after cervical steroid injection, 14 (25.5%) reported complete pain relief, nine (16.4%) reported at least 50% relief, five (9.0%) reported either unchanged or worse pain, and 16 (29.1%) had undergone surgery. Among those providing data at each time point, clinically significant pain relief (change in NRS > 2) was experienced by 17 (30.9%) after one week, by 26 (45.6%) after one month, by 24 (46.2%) after three months, and by 26 (47.4%) after six months. In Table 3A Clinical outcomes during the 6 months after initial cervical steroid injection: Patients providing data at a given time point Tables 3B and 3C , this analysis is repeated after modeling missing data as either no change in pain (Table  3A) or worse pain (Table 3C ). In both scenarios, 19.4% had complete pain relief, 27.8% had partial pain relief, and 22.2% had chosen surgery at six months. There was no change in pain for up to 26.4% (Table 3B) and worse pain for up to 27.8% (Table 3C) .
Discussion
Radicular pain syndromes of spinal origin are often at least partially mediated by pro-inflammatory substances secreted by the nucleus pulposus [14] . Steroids, both oral and injected, are common nonsurgical methods used to treat spinal pain syndromes with radicular features [1] . Many patients will receive both oral and injected steroids as part of their treatment. Patients in our practice who have been treated with oral steroids commonly ask if their response to the oral therapy predicts their response to a cervical epidural steroid injection. We found no difference in pain reduction after cervical epidural steroid injection between those who had experienced pain reduction with prior oral steroid treatment and those who had not, indicating that decisions about treatment with cervical steroid injections should not be influenced by patients' experience with prior oral steroid treatment. Patients need not be pessimistic about pain reduction after cervical epidural steroid injection if they did not experience pain reduction with oral steroid therapy.
Regardless of pain reduction with prior oral steroid treatment, we found a prompt and significant reduction in average pain scores occurring in the first week following a single interlaminar cervical epidural steroid injection. This timing suggests that the response was attributable to the injection. The pain reduction (average decrease in pain of 2 points at one week and 2.6 points at one month) was clinically significant according to criteria established in studies of chronic pain syndromes, where a decrease of at least two points on the numeric rating scale is considered significant [15, 16] . The treatment effect was durable, with 36.4% of patients reporting decreased pain and 25.5% reporting complete relief of symptoms at six months. When all data points were included and modeled either as no change in pain or worse pain, these values were 27.8% and 19.4%, respectively, suggesting that further work is needed to establish the range of potential treatment outcomes.
Epidural steroid injections for cervical pain syndromes are controversial [8, 17] , and despite their common usage, few studies have provided data about the efficacy of these interventions. Often, results are reported as average reduction in pain scores or functional capacity, as done by Cohen et al, for example [8] . This analysis may mask more significant effects for subgroups of patients by including those who report no relief in the aggregate analysis. We showed a prompt and complete reduction in pain scores lasting the full six months of the follow-up period in 25% of our patients. We have demonstrated a significant decrease in pain scores in our study group after cervical steroid injection, providing support for the efficacy of this procedure.
Seventeen patients opted for surgery during the study period. An additional 17 failed to provide a complete data set. In our accumulated clinical experience, the decision to undergo spine surgery is complex. Patients have varying levels of comprehension about the natural history of spine syndromes, the risks of available treatment options, and the meaning of the results of diagnostic tests. Patients are influenced by any number of factors when deciding to pursue surgery; these can include individual pain tolerance, the relationship they establish with their surgeon, the surgeon's particular practice style, the results obtained by friends or family members and even information gleaned from chat rooms or other sites on the internet. Some patients are unaware that additional injections could be offered. Weckbach et al. administered a multiple choice questionnaire that intended to assess the basic knowledge of anatomy, clinical symptoms, and therapies of spinal diseases of patients giving informed consent for spinal surgery [18] . They concluded that "patients do not choose any treatment option based on knowledge" in those areas. Thus, a patient's decision to proceed to surgery may not always be a function of the failure of a particular intervention, and further work is needed to improve our understanding of the factors underlying patients' decisions about surgical intervention.
We did not collect data on what influenced these patients to have surgery. Seven of the 17 patients who opted for surgery reported a decrease in pain after the injection. It is not possible to rule out a continued improvement in the absence of surgery, and thus we may be underestimating the treatment effect of the injection.
Limitations
Limitations of this study include the potential for recall bias, as information about the response to oral steroids was elicited retrospectively up to six weeks after the medication was prescribed. Also of concern is the high loss to follow-up rate. If loss to follow-up is not random but occurs in a way that is related to the prior response to oral steroids, this could introduce bias into our analysis of differences between those who did and did not achieve pain relief with oral steroid treatment. Similarly, if loss to follow-up were related to pain level, this would introduce bias into our analysis of longitudinal changes in pain. We address this by using mixed models analysis, together with presenting an intention to treat data model (Table 3B and C). A further limitation of the study is that, due to size, it was not possible to stratify the prior response to oral steroids beyond binary (yes/no) categories or to stratify outcome data according to initial MRI findings. Larger studies will be needed to determine whether there is a difference in pain reduction after cervical steroid injection between those at the extremes of the oral steroid response spectrum or whether specific MRI findings influence pain reduction after cervical steroid injection.
Conclusion
Prior response to orally administered corticosteroid in patients with cervical radicular pain is not associated with response to subsequent cervical epidural steroid injection. Cervical epidural steroid injection is an effective intervention for pain reduction for some patients with cervical radicular pain. Including modeled data, 47% to 62% of patients with cervical radicular pain experienced some degree of pain reduction lasting six months after a single cervical epidural steroid injection.
